This also concerns external factors, such as effects of the microenvironment or the role of the immune system: Our model, through the flexibility regarding mutational events and their consequences, can also be used to make specific assumptions about tumor-immune cell interactions, for example assuming a higher immune visibility of MMR-deficient cell clones with high mutation load, which is part of future work. This evidence concerns the gene MRC1 and neoplasm.